Salicylic acid inhibition of the irreversible effect of acetylsalicylic acid on prostaglandin synthetase may be due to competition for the enzyme cationic binding site

D. A. Peterson, J. M. Gerrard, G. H.R. Rao, J. G. White

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Salicylic acid (SA), a weak inhibitor of the prostaglandin endoperoxide synthetase or fatty acid cyclooxygenase enzyme, is known to prevent irreversible enzyme inhibition by acetylsalicylic acid (ASA). The interaction of arachidonic acid with ferrous sulfate was used as a model to study the reaction of the fatty acid with the postulated enzymic cationic binding site on Fe2+-heme. SA was as potent as ASA in inhibiting the cooxygenation of arachidonic acid and ferrous sulfate. The result suggests that SA could compete effectively for the enzyme cationic site with ASA. Thus SA may block ASA acetylation of the cyclooxygenase by preventing ASA from binding to this site.

Original languageEnglish (US)
Pages (from-to)161-164
Number of pages4
JournalProstaglandines and Medicine
Volume6
Issue number2
DOIs
StatePublished - Feb 1981

Fingerprint Dive into the research topics of 'Salicylic acid inhibition of the irreversible effect of acetylsalicylic acid on prostaglandin synthetase may be due to competition for the enzyme cationic binding site'. Together they form a unique fingerprint.

Cite this